Razaq 2011.

Methods	Prospective randomised control trial carried out at Al‐Elwiya Maternity Teaching Hospital, Baghdad.
Participants	150 pregnant women were randomised. Inclusion criteria: primiparous women, singleton fetus with uncomplicated pregnancy, admitted for post‐dates induction. Exclusion criteria: obstetric, gynaecological or medical problems.
Interventions	Out of 150 women randomised, 75 received 40 mg IMN vaginally in the form of two 20 mg tablets and 75 received 50 mcg misoprostol vaginally. The process was repeated in the misoprostol group every 6 hours if the Bishop scores did not improve for a maximum of 3 doses.
Outcomes	Maternal: delivery interval, mode of delivery, adverse effects. Neonatal: general outcomes (not prespecified).
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	'Randomised', no further details given.
Allocation concealment (selection bias)	Unclear risk	Unclear.
Incomplete outcome data (attrition bias) All outcomes	Low risk	No evidence to the contrary.
Selective reporting (reporting bias)	High risk	Outcomes not clearly specified in the text.
Other bias	Low risk	No evidence to the contrary.
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Unclear.
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Unclear.